Loading viewer...
earnings
Format: PDF earnings
Amgen's Q2 2023 earnings presentation delivered on August 3, 2023, includes forward-looking statements on product performance, acquisitions including Horizon Therapeutics, and financial guidance. The deck covers clinical developments, commercial updates, and strategic initiatives across Amgen's biopharmaceutical portfolio. Risk factors and safe harbor disclosures detail regulatory, manufacturing, and competitive challenges affecting the company's operations.
earnings
14 Pages
Aimia
Essent Group Q3 2016 Earnings Presentation
earningsearnings
8 Pages
Essent Group Limited
Pact Group Holdings 2022 Full Year Results Earnings Presentation
earningsearnings
31 Pages
Pact Group Holdings Ltd